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Abstract
Background: The non-pathogenic bacterium Mycobacterium smegmatis is widely used as a near-native expression
host for the purification of Mycobacterium tuberculosis proteins. Unfortunately, the Hsp60 chaperone GroEL1, which
is relatively highly expressed, is often co-purified with polyhistidine-tagged recombinant proteins as a major
contaminant when using this expression system. This is likely due to a histidine-rich C-terminus in GroEL1.
Results: In order to improve purification efficiency and yield of polyhistidine-tagged mycobacterial target proteins,
we created a mutant version of GroEL1 by removing the coding sequence for the histidine-rich C-terminus, termed
GroEL1ΔC. GroEL1ΔC, which is a functional protein, is no longer able to bind nickel affinity beads. Using a selection
of challenging test proteins, we show that GroEL1ΔC is no longer present in protein samples purified from the
groEL1ΔC expression strain and demonstrate the feasibility and advantages of purifying and characterising proteins
produced using this strain.
Conclusions: This novel Mycobacterium smegmatis expression strain allows efficient expression and purification of
mycobacterial proteins while concomitantly removing the troublesome contaminant GroEL1 and consequently
increasing the speed and efficiency of protein purification.
Background
Heterologous expression of recombinant proteins in
Escherichia coli can result in the production of insoluble
inclusion bodies. Recent statistics show that less than
half of the M. tuberculosis (Mtb) proteins expressed in
E. coli are soluble [1]. Therefore, the non-pathogenic
bacterium Mycobacterium smegmatis is often used as an
alternative, more closely related host for the expression
of mycobacterial proteins. Furthermore, M. smegmatis
may also provide mycobacterium-specific chaperones,
which can help correct folding of Mtb proteins [1].
During nickel affinity purification, it has been
observed that a protein of 56 kDa is co-purified with
polyhistidine-tagged recombinant proteins while using
M. smegmatis as an expression system. This contami-
nant was previously identified as the Hsp60 chaperone
GroEL1 of M. smegmatis [1-3]. The protein sequence of
GroEL1 shows a histidine-rich C-terminus (7 out of 11
amino acids are histidines), which is likely to be the rea-
son for the observed nickel sepharose binding [1,2].
Unlike most other bacteria, mycobacteria possess two
Hsp60 chaperone groEL genes, one of which is arranged
in the bicistronic groESL operon [4]. M. smegmatis also
encodes a third Hsp60 protein (Msmeg1978), which is
more distantly related to GroEL1 (Msmeg1583) and
GroEL2 (Msmeg0880) [3]. Although groEL1 of M. smeg-
matis can be found in the same operon as groES,a n
arrangement indispensable for the chaperone function
in bacteria, its histidine-rich tail is distinct from the
more typical glycine-methionine-rich C-terminal region
found in GroEL2 [3]. Furthermore, groEL2 is an essen-
tial gene and exists in all actinobacteria, in contrast to
groEL1 [3,5]. Recently, it has been shown that groEL2
and groES are expressed more strongly than groEL1,
which might have arisen from a difference in stability of
the predicted post-transcriptionally cleaved mRNAs for
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perone model in mycobacteria, one chaperone, here
GroEL2, would act as the main house keeping chaper-
one in M. smegmatis, with the other chaperones
(GroEL1 and Msmeg1978) adopting more specialised
functions. Indeed, GroEL1 of M. tuberculosis was
recently identified as being associated with nucleotides,
suggesting a role as a DNA chaperone, while GroEL1 of
M. smegmatis was found to have a role in mycolic acid
biosynthesis during biofilm formation [5,6,3].
The co-purification of GroEL1 with histidine-tagged
recombinant proteins can be particularly problematic
since native GroEL1 is expressed at relatively high levels,
meaning that in the case of a low yield of recombinant
protein, GroEL1 may well compete with the protein of
interest for binding sites on nickel affinity beads. Mini-
mal sample manipulation is recommended during pro-
tein purification to improve efficiency. Therefore,
additional steps required to remove GroEL1 can result
in a significant loss of the protein of interest.
In this article, we describe an M. smegmatis expres-
sion strain containing a mutant version of GroEL1,
termed GroEL1ΔC, which consists of a groEL1 gene
without a coding sequence for the histidine-rich C-terminal
tail. We show that GroEL1ΔC is a functional protein,
which no longer co-purifies when using nickel affinity puri-
fication and we provide evidence that proteins purified
from this strain are correctly folded, active and that they
behave identically to those purified from the original
expression strain. Taken together, our data demonstrate
that M. smegmatis groEL1ΔC is a competent protein
expression strain, which allows the efficient removal of the
troublesome contaminant GroEL1 without the require-
ment of additional purification steps.
Methods
Bacterial strains and media
The E. coli strains DH5a (Invitrogen) and HB101 (Pro-
mega) were used for cloning of expression constructs
and the target substrate to generate the mutant version
of groEL1 using standard procedures [7]. Transformants
were selected in Luria Broth containing the appropriate
antibiotics.
M. smegmatis mc
21 5 5w a su s e da st h ep a r e n t( w i l d
type) strain for the groEL1ΔC strain. Both M. smegmatis
strains were maintained in Middlebrook 7H9 or 7H10
medium supplemented with 0.2% (v/v) glycerol, 10%
ADC, 0.05% (v/v) tween-80 and the appropriate
antibiotics.
For biofilm formation, 10 ml of biofilm media was
inoculated with 10 μl of saturated culture and incubated
at 30°C without disturbance [3,8].
For the expression of the recombination proteins in
M. smegmatis in order to create the mutant form of
groEL1, 0.2% succinate (w/v) was added as a carbon
source to 7H9 medium supplemented with 0.2% (v/v)
glycerol, 0.05% (v/v) tween and the appropriate antibio-
tics. Expression of his-tagged recombinant proteins in
M. smegmatis was performed in 7H9 medium supple-
mented with 0.2% (w/v) glucose as carbon source. Acet-
amide was added to a final concentration of 0.2% (w/v)
at 0.5 OD600 and at 2.5 OD600 for the expression of the
recombination proteins and his-tagged recombinant pro-
teins, respectively.
Plasmids, constructs and oligonucleotides
All plasmids and constructs are summarised in Table 1
and oligonucleotides are listed in Table 2. pJV53 was
used to express the recombination proteins [9].
pYUB854 was used for the preparation of the target
substrate to create the groEL1ΔC strain [10]. pGH542,
harbouring a δg resolvase, was used to generate an
unmarked deletion [11]. Using the primer pairs
Msmeg1583-F1.2 & Msmeg1583-R1 and Msmeg1583-F2
& Msmeg1583-R2.1, two 500 bp fragments, homologous
to the fragments +1067/+1587 and +1621/+2176 relative
to the translational start of Msmeg1583, were amplified
Table 1 Plasmids and constructs used in this study
Plasmid/
construct
Description Reference
pJV53 Che9c recombination proteins under
control of the acetamidase promoter in
pLAM12
[9]
pYUB854 Hyg
R cassette flanked by gδ-res sites
and 2 MCSs
[10]
pGH542 Expressing an gδ resolvase and
tetracycline resistant
[11]
pEN15 pYUB854 with a 520 bp fragment
harbouring groEL1 (+1067/+1587,
relative to groEL1) inserted upstream of
the Hyg
R cassette and a 555 bp
fragment downstream of groEL1
including the STOP codon of groEL1,
inserted downstream of the Hyg
R
cassette
This paper
pMyNT Mycobacterial overexpression vector Geerlof et al.,
unpublished
data
pMyNT/
PrcA-B
Rv2109-2110 in pMYNT, Rv2110 is N-
terminally his-tagged
[12]
pMyNT/
AccD5E5
Rv3280-3281 in pMYNT. Only his-
tagged Rv3280 seems to express using
this construct.
This paper
pMyNT/
AccA3
Rv3285 in pMyNT This paper
pMyNT/
CFP10-
ESAT6
Rv3874-3875 in pMYNT, Rv3874 is N-
terminally his-tagged
[12]
pMyNT/
ACPS
Rv2523 in pMYNT This paper
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Page 2 of 9and subsequently ligated AflII-XbaI( F 1 . 2 - R 1 )a n dHin-
dIII-SpeI (F2-R2.1) into pYUB854, creating pEN15.
For the expression of M. tuberculosis proteins in
M. smegmatis, the pMyNT expression vector was used
[Geerlof et al., unpublished data]. pMyNT/ACPS,
pMyNT/AccA3 and pMyNT/AccD5 were made as fol-
lows: PCR was performed with primer pair Rv2523-F &
Rv2523-R for ACPS, accA3-F & accA3-R for AccA3 and
accD5E5-F & accD5E5-R for AccD5 and the resulting
fragments were digested with NcoI-HindIII and inserted
into NcoI-HindIII digested pMyNT.
Creation of the groEL1ΔC mutant
The groEL1ΔC mutant was created using the mycobac-
terial recombineering method [9]. pEN15 was digested
with AflII and SpeI to create the linear target substrate,
which was introduced into mc
2155 electrocompetent
cells, expressing the recombinase genes on pJV53 and in
this way creating hygromycin-resistant transformants.
The hygromycin-resistance cassette was removed using
δg resolvase, expressed on pGH542, generating an
unmarked deletion [11].
Southern blot analysis
Genomic DNA (5ug) was isolated as described [9],
digested with the appropriate enzymes, separated on a
0.9% agarose gel and transferred to a positively charged
nylon membrane (Roche). For DNA probe labelling,
hybridisation and detection, the DIG high prime DNA
labelling and detection starter kit 1 (Roche) was used.
Growth curves
Bacterial growth was followed by measuring the optical
densities at a wavelength of 600 nm as a function of
time. Cultures were prepared with 7H9 expression med-
i u m( 0 . 2 %( w / v )g l u c o s ea sc a r b o ns o u r c e )i ni d e n t i c a l
triplicates for each strain. Duplicate samples were taken
every 4 hours for 40 hours. When the optical density at
600 nm exceeded 1.5, samples were diluted in order to
remain within the linear range of the detector.
Protein expression and purification
All methods related to protein expression in M. smegmatis
were carried out as described [12,13]. Protein-protein
complexes from operon-encoded proteins were expressed
using the native operon structure [9]. In brief, pellets
from 500 ml cultures were dissolved in 30 ml lysis buffer
containing 50 mM Tris-HCl pH 8.0, 300 mM NaCl,
0.5 M urea with protease inhibitor cocktail (Sigma) and
1 mg/ml DNase I (Serva). Resuspended cells were
sonicated four times, each for 5 min (with a 0.3 s
p u l s ea n d0 . 7sr e s t )a t5m i ni n t e r v a l st op r e v e n t
overheating, using a Bandelin VW3200 probe at 45%
amplitude. The supernatant was collected after centri-
fugation (30,000 × g) for 1 h at 4°C, filtered through a
0.44 μm filter and loaded onto a nickel affinity sephar-
ose (NiAC) column. After washing with 10 column
v o l u m e so f5 0m MT r i s - H C lp H8 . 0 ,3 0 0m MN a C la n d
20 mM imidazole, proteins were eluted in 50 mM Tris-
HCl, 100-150 mM NaCl and 250-500 mM imidazole
and subjected to size exclusion chromatography using
either a Superdex 75 (16/60) column (GE Healthcare)
or, for large protein complexes, a Superose 6 (10/300)
(GE Healthcare) with 25 mM Tris-HCl pH 8.0, 150 mM
NaCl and 1 mM DTT as buffer. The collected protein
samples were analysed by SDS-PAGE and concentrated
accordingly.
Circular Dichroism (CD) spectrum analysis
CD measurements were performed on a Jasco J-810
spectropolarimeter. Prior to measurement, samples were
dialysed into 10 mM potassium phosphate, 150 mM
NaCl, pH 7.4. Spectra were recorded between 182 and
260 nm in a 2 mm cuvette with machine settings as
Table 2 Primers used in this study
Primer Sequence (5’-3’) Location 5’ Relative to
Msmeg1583-F1.2 GCGCCTTAAGCGACTGGGATCGCGAGAAGCTGC +1067 Msmeg1583
Msmeg1583-R1 GCGCTCTAGACTCGTCCTCGTCGGCCGGCTTG +1587 Msmeg1583
Msmeg1583-F2 GCGCAAGCTTGATCCATTTCACGCGACACCCCC +1620 Msmeg1583
Msmeg1583-R2.1 GCGCACTAGTGGTGTTCGATCGTCTGGCCGATG +2176 Msmeg1583
accD5E5-F GATCTCATGAGTATGACAAGCGTTACC G +1 Rv3280
accD5E5-R GTCAAAGCTTTTATCGGCGCATGTGCG +2161 Rv3280
accA3-F GATCCCATGGGTATGGCTAGTCACGCC +2 Rv3285
accA3-R GTCAAAGCTTTTACTTGATCTCGGCGAGC +1803 Rv3285
Rv2523-F CATGCCATGGGCATCGTCGGTGTGGGG +1 Rv2523
Rv2523-R CCCAAGCTTACGGGGCCTCCAGGATGGC +391 Rv2523
Restriction sites are presented in bold face. CTTAAG = EcoRI, TCTAGA = XbaI, CCATGG = NcoI, TCATGA = BspHI.
AAGCTT = HindIII, ACTAGT = SpeI.
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pitch, 100 nm/min scan speed, cell length of 0.1 cm.
Each curve presented is the average of three separate
measurements.
Coupled enzyme assay
Enzymatic activity of the AccD5-AccA3 complex was
estimated by a coupled enzyme assay that follows the
rate of ATP hydrolysis spectrophotometrically [14]. The
production of ADP during the reaction was coupled to
pyruvate kinase and lactate dehydrogenase, and the oxi-
dation of NADH was probed at 340 nm. The assay mix-
ture contained 7 units of pyruvate kinase, 10 units of
lactate dehydrogenase, 50 mM NaHCO3,3m MA T P ,
0.5 mM phosphoenol pyruvate, 0.2 mM NADH, 0.3 mg/
ml BSA, 100 mM K2HPO4 pH 7.6 and 5 mM MgCl2
and varying concentrations of propionyl-coenzyme A.
Reactions were initiated by the addition of enzyme to
the assay mixture and were maintained at 30°C. Data
were acquired using a Tecan infinite M1000 microplate
reader. The kinetic parameters Km and Vmax were deter-
mined by fitting the mean velocities versus the substrate
concentration to the Michaelis-Menten equation of
enzyme kinetics using nonlinear regression analysis, exe-
cuted by the program Prism 5 (GraphPad Software™).
Results and Discussion
Creation of the groEL1ΔC strain
Currently, the role of GroEL1 in protein folding is
uncertain. A closer look at the structure of E. coli
GroEL [15] indicates that, although the C-terminal
region of the protein is not easily accessible, pointing
towards the central cavity of the wheel-like structure
adopted by oligomeric GroEL, the extreme C-terminal
20 amino acids are absent from the model. Similarly,
the GroEL structure of Paracoccus denitrificans also
lacks these residues [16]. These observations suggest
that the C-terminal region of GroEL is highly flexible
and could reach out of the central cavity, allowing in
this way M. smegmatis GroEL1 to bind nickel affinity
beads. Additionally, as native GroEL1 from M. tuberculosis
is oligomeric [17], nickel binding would require only one
accessible histidine-rich region. Therefore, we decided to
change only the last eleven amino acids of the protein,
rather than to make a full knock out strain, in order to
minimise changes to the expression strain. A precise
chromosomal deletion of fragment 1588-1620, relative to
the translational start of groEL1 (Msmeg1583), was cre-
ated using the mycobacterial recombineering technique
[9] (Figure 1A). Southern hybridisation (Figure 1B) was
used to verify that correct homologous recombination
had taken place in the hygromycin-resistant and the
unmarked deletion strain (Figure 1B). The latter strain, in
which the hygromycin resistance cassette has been
removed, has the C-terminal eleven residues of GroEL1,
containing seven histidines, replaced by six non-histidine
residues, which are part of the “scar” sequence left behind
after removal of the resistance cassette (Figure 1A). The
stop codon of this recombinant version of GroEL1 is
TAA, which although rare, is recognised in high G+C
mycobacteria [18]. This unmarked deletion strain,
referred to as M. smegmatis groEL1ΔC,i su s e di na l l
further experiments.
Ojha et al. reported that the last 18 amino acids of
GroEL1 are essential for the formation of mature bio-
films [3]. Therefore, to test the functionality of the
GroEL1ΔC protein, we compared biofilm formation in
both the wild type and groEL1ΔC strains. Both strains
were able to form mature biofilms after an incubation
time of 7 days at 30°C, indicating that GroEL1ΔCi s
indeed fully functional (Figure 2A). Taking into account
the data from Ojha et al., our results could suggest that
either the amino acids important for biofilm formation
are upstream of those removed in the GroEL1ΔCp r o -
tein, or that removal of the last 18 residues may affect
the folding of at least a part of GroEL1. Additionally, as
this newly created strain was constructed for the overex-
pression of mycobacterial proteins, its growth in 7H9
expression medium was compared to the original
expression strain M. smegmatis mc
2155 (Figure 2B). We
observed no significant differences in growth between
the two strains, with both reaching an OD600 of between
2.5-3.0 after approximately 18 hours, at which time
expression is usually induced.
GroEL1ΔC is absent during nickel affinity purification of
proteins expressed in M. smegmatis groEL1ΔC
To demonstrate the absence of GroEL1ΔCa sac o n -
taminant when using the M. smegmatis groEL1ΔC
expression strain, we determined the expression and
purification efficiency of our strain in comparison to the
wild type strain using five different constructs, repre-
senting a variety of different protein molecules, includ-
ing the mycobacterial proteasome, the CFP10-ESAT6
complex, the AccD5-AccA3 dodecameric acyl-CoA car-
boxylase complex and the holo-acyl-carrier protein
synthase (for details, see Table 3). Additionally, we also
used the empty pMyNT vector, to check for GroEL1
binding in the absence of a his-tagged protein. All con-
structs were transformed into both M. smegmatis
mc
2155 and groEL1ΔC and the resulting transformants
were cultured in 7H9 expression medium and induced
by the addition of acetamide to a final concentration of
35 mM. Eighteen hours after induction, the cells were
collected by centrifugation, lysed and the soluble protein
fraction was passed over a nickel affinity column, with
the elution fraction being analysed by SDS-PAGE
(Figure 3). While GroEL1 was visible in samples purified
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2155 (Figure 3, lanes a), the protein
was noticeably absent in five out of six protein samples
isolated from the groEL1ΔC strain (Figure 3, lanes b). Due
to the fact that AccD5 has a similar size to GroEL1,
we were unable to determine its presence or absence
in samples of the purified acyl-CoA carboxylase com-
plex by SDS-PAGE. Therefore, samples isolated from
gel (Figure 3) were analyzed by mass spectrometry
(Additional file 1). While numerous peptides from
both GroEL1 and AccD5 could be identified from gel
slices deriving from the mc
2155 strain, only AccD5
peptides could be detected in the sample obtained
from the groEL1ΔC strain (Additional file 1). Likewise,
MALDI-TOF mass spectrometry was performed on the
other protein samples, verifying the absence of GroEL1
peptides in the protein samples derived from M. smeg-
matis groEL1ΔC (data not shown).
Proteins purified from M. smegmatis groEL1ΔC behave
identically to those purified from the wild type strain
M. smegmatis encodes three forms of the Hsp60 chaper-
one GroEL: Msmeg1583 (GroEL1), Msmeg0880
(GroEL2) and Msmeg1978. However, the precise mole-
cular function of each protein remains unclear.
Figure 1 Construction of the groEL1ΔC strain. (A) A schematic representation of the genomic organisation of groEL1 (Msmeg1583) in
M. smegmatis mc
2155 (1), the hygromycin-resistant groEL1ΔC mutant (2) and the unmarked groEL1ΔC deletion strain (3). Msmeg1582 is groES and
Msmeg1581, 1584, 1585 and 1586 encode for proteins of unknown function. Zoom sequence of the C-terminal 40 amino acids of the groEL1
gene product, showing the histidine-rich C-terminal region. In the groEL1ΔC strain, the eleven C-terminal amino acids (white) were replaced by
six different residues. Hyg
R = hygromycin-resistance cassette. (B) Southern blot analysis performed with genomic DNA of M. smegmatis mc
2155
(1), mc
2155 carrying pJV53 (2), two correct hygromycin-resistant groEL1ΔC mutants (3-4) and two correct unmarked groEL1ΔC deletions (5-6). The
genomic DNA was digested with EcoRI or SacI. The positions of the restriction sites EcoRI and SacI, relative to the start of groEL1, are presented
as a full and dotted vertical line in A, respectively. The PCR product of primer pair Msmeg1583-F1.2 & Msmeg1583-R1 was used as a probe,
shown as a dashed line under the genes in A1. (M) DNA marker VII, DIG labelled (Roche).
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alter growth but does result in a strong defect in biofilm
formation [3]. To confirm that the newly created recom-
binant version of GroEL1 has no effect on the correct
folding and, ultimately, the function of the proteins
expressed in M. smegmatis groEL1ΔC, a number of dif-
ferent proteins and protein complexes have been
expressed and analysed.
In the previous section, we have shown that it is
possible to express and purify potentially challenging
protein complexes, such as the proteasome complex
PrcA-B and the CFP10-ESAT6 complex, from the
recombinant groEL1ΔC strain. These data imply that the
proteins isolated from the groEL1ΔC strain are correctly
folded, since we were able to observe all components
after purification. In both examples, complex formation
Figure 2 Biofilm formation and growth rates of M. smegmatis mc
2 155 and M. smegmatis groEL1ΔC are comparable.( A )B o t hM.
smegmatis mc
2 155 (WT) and M. smegmatis groEL1ΔC strains are able to form biofilms after an incubation time of 7 days at 30°C. (B) Growth
curve of M. smegmatis mc
2155 (WT = black) and M. smegmatis groEL1ΔC strains (grey) in 7H9 expression medium. The arrow represents the
typical time of induction in M. smegmatis.
Table 3 List of test proteins used to validate the groEL1ΔC expression strain
ORF Annotation Description Expressed ... Mol.
Mass
(kDa)
Rv2109c
Rv2110c
PrcA
PrcB
a- and b-subunit of the mycobacterial proteasome
(a7b7b7a7 subunit organisation)
Using native operon content, producing a 730
kDa multimeric complex
26.8
30.3
Rv3285
Rv3280
AccA3
AccD5
a- and b-subunit from acyl-CoA carboxylase AccD5-
AccA3 complex (a3b3b3a3 subunit organisation)
As monomeric proteins, mixed to form a acyl-
CoA carboxylase complex of 740 kDa
63.8
59.4
Rv3874
Rv3875
CFP10
ESAT6
Potential virulence factor CFP10-ESAT6 complex Using native operon content, producing a
heterodimeric (1:1) complex
10.8
9.9
Rv2523c ACPS Holo-acyl-carrier protein synthase As monomeric protein 14
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units of the complex as only one subunit is his-tagged.
Taking our analysis one step further, we directly tested
the structural and functional properties of proteins iso-
l a t e df r o mt h egroEL1ΔC strain. We used the five
expression constructs described above and transformed
them into both M. smegmatis mc
2155 and groEL1ΔC.
Proteins were expressed and purified using a nickel affi-
nity column as described above. AccD5 and AccA3 pro-
tein samples were mixed in a 1:1 stoichiometry to form
the high-molecular-weight AccD5-AccA3 complex. Size
exclusion chromatography was performed on all samples
as a final purification step.
Circular dichroism (CD) spectroscopy is a powerful
tool used to visualise the secondary structure properties
of protein samples. We observed that the four protein
samples isolated from groEL1ΔC gave virtually identical
CD spectra to those purified from the wild type strain
(Figure 4), implying that they are correctly folded.
Furthermore, the CD spectra of the CFP10-ESAT6 com-
plexes, showing a protein with high helical content, are
comparable to those collected previously [12] and are in
line with the X-ray structure, which consists of a four-
helical bundle complex (PDB ID: 3FAV) [12].
Additionally, we have demonstrated carboxylase activ-
ity of the acyl-CoA carboxylase AccD5-AccA3 complex,
isolated from groEL1ΔC, using an enzyme-coupled reac-
tion (Figure 5). Using propionyl-CoA as a substrate,
AccD5-AccA3 showed carboxylase activity with a Km =
0.1301 ± 0.0198 mM and a Vmax = 1.333 ± 0.049 mM
min
-1 mg
-1, data which are similar to the parameters
determined using the AccD5-AccA3 complex isolated
from E. coli [19], indicating that the AccD5-AccA3 com-
plex isolated from groEL1ΔC is a functional carboxylase.
Carboxylase activity requires the a-subunit of the car-
boxylase to be post-translationally biotinylated [19],
implying that the subunits of this large megasynthase
are folded correctly and, in the case of the a-subunit,
correctly post-translationally modified, when isolated
from groEL1ΔC.
Conclusions
We have developed an M. smegmatis expression strain
that allows efficient expression and purification of
mycobacterial proteins, multi-subunit protein complexes
and post-translationally modified proteins while conco-
mitantly removing the troublesome contaminant
GroEL1 and consequently increasing the speed and effi-
ciency of protein purification. The M. smegmatis
groEL1ΔC strain is particularly suitable for laboratories
performing in vitro activity assays and structural studies
on mycobacterial proteins and protein complexes.
Figure 3 GroEL1ΔC is absent from protein samples purified from M. smegmatis groEL1ΔC. SDS-PAGE analysis of protein samples isolated
from cells expressing either CFP10-ESAT6 heterodimer (1), a holo-acyl-carrier protein synthase (ACPS) (2), the b- and a-subunit D5 (3) and A3
(4) of the acyl-CoA carboxylase AccD5-AccA3 complex, the PrcA-B complex (5) or the empty expression vector (empty pMyNT) (6). a, proteins
expressed in M. smegmatis mc
2155; b, proteins expressed in M. smegmatis groEL1ΔC. Purified proteins of interest are labelled with #. Visible
presence of GroEL1 is depicted with *. Squares identify the bands excised for peptide mass fingerprinting. GroEL1 = 56 kDa.
Noens et al. BMC Biotechnology 2011, 11:27
http://www.biomedcentral.com/1472-6750/11/27
Page 7 of 9Additional material
Additional file 1: GroEL1 is absent from an AccD5 protein sample
derived from M. smegmatis groEL1ΔC. Results of peptide mass
fingerprinting analysis of samples excised from SDS-PAGE gel (Figure 3,
boxes). Shown in red are the peptides that could be identified. (a)
Sample derived from M. smegmatis mc
2155. (b) Sample derived from M.
smegmatis groEL1ΔC.
Abbreviations
PCR: Polymerase chain reaction; kDa: kilo Dalton; Hsp60: Heat shock protein
60; ADC: Albumine-dextrose-catalase; DMSO: dymethylsulfoxide; NiAc: Nickel
affinity sepharose column; SDS-PAGE: sodium dodecyl sulfate polyacrylamide
gel electroporesis; MALDI-TOF: matrix-assisted laser desorption/ioization
reflection time-of-flight.
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2155 (WT = black) and M. smegmatis groEL1ΔC (grey) are virtually identical. For A and B, a concentration between 170 and
200 nM was used while for C and D, concentrations were between 5 and 10 μM.
Figure 5 Kinetics of AccD5-AccA3 isolated from M. smegmatis
groEL1ΔC. Carboxylation activity of the acyl-CoA carboxylase
AccD5-AccA3 complex isolated from groEL1ΔC was measured using
an enzyme-coupled reaction with propionyl-CoA as substrate,
providing Km = 0.1469 mM and Vmax = 28.5 mOD/min.
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